OM Pharma is an international biopharmaceutical company specializing in the prevention of respiratory and urinary tract infections. As a committed local player, we train and support the talents of tomorrow through meaningful and educational internships.
In this context, we are offering a paid 6 to 12-month internship, ideally starting as soon as possible or at the beginning of 2027, based at our headquarters in Meyrin. Under the supervision of the Regulatory Operations Team Lead and in close collaboration with the RA team and external partners, your mission is to support regulatory operations activities related to regulatory data management, dossier maintenance and electronic submissions, ensuring the quality, accuracy and compliance of regulatory information throughout the product lifecycle.
To carry out these activities, we are looking for a person with the following profile:
You are a detail-oriented, organized and proactive individual with a strong willingness to learn. After receiving initial guidance, you are able to work independently, take ownership of your tasks and ensure a high level of accuracy and quality in your work. You enjoy working with data and documentation, are comfortable interacting with different stakeholders and thrive in a collaborative and multicultural environment. Your rigorous approach, team spirit and commitment to compliance make you a valuable contributor to the Regulatory Affairs team.
Looking for a first hands-on experience in Regulatory Operations within the pharmaceutical industry? Join us and make a meaningful contribution to healthcare products used worldwide. We look forward to receiving your application and getting to know you!
IMPORTANT: This internship is only open to students whose academic programme requires a mandatory internship as part of the degree curriculum. Candidates must be able to provide a valid tripartite internship agreement, and the internship duration must meet the minimum requirements set by their educational institution.
OM Pharma is a global Geneva-based biopharmaceutical company. It is a leader in the prevention of recurrent respiratory and urinary tract infections and is also active in the treatment of vascular diseases.
It operates worldwide through a strong network of international partners and invests its profits in R&D to develop microbial derived immunotherapeutic products to treat acute and chronic immunological disorders resulting from inflammation and infections.
The company strives to improve the quality of life of patients around the world by providing access to better treatment of immunological imbalances.
For more information, visit the website: ompharma.com.

We use our expertise in bacterial lysates to address the world’s most significant health challenges from the rise in infectious disease outbreaks to antimicrobial resistance.
Currently active in the prevention of respiratory and urinary tract infections, our constantly evolving understanding of how bacterial lysates interact with the immune system motivates us to invest in new indications and new formulations for our lysates.
Headquartered in Geneva with affiliates in Peru and Switzerland, our products are available in more than 100 countries through a network of trusted partners.